MAPT and Alzheimer disease: The site at which BTA-EG4 reduced tau phosphorylation in 3xTg-AD slice cultures (Ser202, recognised by antibody CP13) is a known target of both GSK-3 and Cdk538, 39, therefore we investigated the effect of BTA-EG4 on the activities of these kinases.